171
Participants
Start Date
February 29, 2012
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Dapagliflozin
Tablets, Oral, 1 mg, Once daily, 14 days
Placebo matching Dapagliflozin
Tablets, Oral, 0 mg, Once daily, 14 days
Progressive Medical Research, Port Orange
Compass Research Phase 1, Llc, Orlando
Central Kentucky Research Associates, Inc., Lexington
Jasper Clinic, Inc., Kalamazoo
Regional Medical Clinic-Endocrinology, Rapid City
Kansas City University Of Medicine And Biosciences, Kansas City
Vince And Associates Clinical Research, Overland Park
Louisiana Research Associates, Inc., New Orleans
Dallas Diabetes & Endocrine Center, Dallas
La Biomed Research Inst. At Harbor Ucla Med Ctr., Torrance
Profil Institute For Clinical Research, Inc., Chula Vista
Va San Diego Healthcare System, San Diego
Lead Sponsor
Collaborators (1)
Astra Zeneca, Bristol-Myers Squibb
OTHER
AstraZeneca
INDUSTRY